Dual-target virtual screening by pharmacophore elucidation and molecular shape filtering.

Dual-target inhibitors gained increased attention in the past years. A novel in silico approach was employed for the discovery of dual 5-lipoxygenase/soluble epoxide hydrolase inhibitors. The ligand-based approach uses excessive pharmacophore elucidation and pharmacophore alignment in conjunction with shape-based scoring. The virtual screening results were verified in vitro, leading to nine novel inhibitors including a dual-target compound.

[1]  Pomila Singh,et al.  Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases , 2009, Drugs of the Future.

[2]  P. Jaccard,et al.  Etude comparative de la distribution florale dans une portion des Alpes et des Jura , 1901 .

[3]  C. Bron,et al.  Algorithm 457: finding all cliques of an undirected graph , 1973 .

[4]  Ray A. Jarvis,et al.  Clustering Using a Similarity Measure Based on Shared Near Neighbors , 1973, IEEE Transactions on Computers.

[5]  Wendy A. Warr,et al.  ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI) , 2009, J. Comput. Aided Mol. Des..

[6]  Bruce D Hammock,et al.  Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs). , 2007, Prostaglandins & other lipid mediators.

[7]  W. Kabsch.  A discussion of the solution for the best rotation to relate two sets of vectors , 1978 .

[8]  D. Steinhilber,et al.  Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Richard Morphy,et al.  Designing multiple ligands - medicinal chemistry strategies and challenges. , 2009, Current pharmaceutical design.

[10]  F. Sams-Dodd.  Target-based drug discovery: is something wrong? , 2005, Drug discovery today.

[11]  Gisbert Schneider,et al.  „Grundgerüstwechsel”︁ (Scaffold‐Hopping) durch topologische Pharmakophorsuche: ein Beitrag zum virtuellen Screening , 1999 .

[12]  W. Kabsch.  A solution for the best rotation to relate two sets of vectors , 1976 .

[13]  Richard Morphy,et al.  From magic bullets to designed multiple ligands. , 2004, Drug discovery today.

[14]  Oliver Werz,et al.  Therapeutic options for 5-lipoxygenase inhibitors. , 2006, Pharmacology & therapeutics.

[15]  S. Hwang,et al.  Inhibition of the Soluble Epoxide Hydrolase Promotes Albuminuria in Mice with Progressive Renal Disease , 2010, PloS one.

[16]  Mark S. Johnson,et al.  ShaEP: Molecular Overlay Based on Shape and Electrostatic Potential , 2009, J. Chem. Inf. Model..

[17]  Schmid,et al.  "Scaffold-Hopping" by Topological Pharmacophore Search: A Contribution to Virtual Screening. , 1999, Angewandte Chemie.

[18]  S. Hwang,et al.  Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model. , 2010, Biochemical pharmacology.

[19]  Richard Morphy,et al.  Designed Multiple Ligands. An Emerging Drug Discovery Paradigm , 2006 .

[20]  Luhua Lai,et al.  Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching. , 2008, Journal of medicinal chemistry.

[21]  B. Hammock,et al.  Measurement of Soluble Epoxide Hydrolase (sEH) Activity , 2007, Current protocols in toxicology.

[22]  Gisbert Schneider,et al.  Shapelets: Possibilities and limitations of shape‐based virtual screening , 2008, J. Comput. Chem..